Glucocortiocoid-selective antiinflammatory agents
US6380207B2 · kind B2 · utility
22Cited by
7References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 13, 1998 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | Feb 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having Formula I are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor in a mammal and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.